Microbot Medical Inc. 8-K

What Happened
Microbot Medical Inc. announced on June 9, 2026 (via Form 8‑K Items 7.01 and 8.01) that it has secured its first Midwest‑based account — a healthcare system in Michigan. The filing includes a press release (Exhibit 99.1) and a Regulation FD disclosure; it also references the company’s forward‑looking statements. The company did not disclose financial terms or specific product details in the 8‑K.

Key Details

• Filing date: June 9, 2026 (Form 8‑K, Items 7.01 and 8.01).
• New account: identified as a healthcare system located in Michigan (first Midwest account for Microbot).
• Exhibits filed: Exhibit 99.1 — press release; Exhibit 104 — interactive cover page data.
• No revenue figures, contract value, or timing for product deployment were provided in the filing.

Why It Matters
This item signals commercial progress and geographic expansion for Microbot into the U.S. Midwest, which could help grow its sales pipeline and future revenue opportunities. For investors, the filing confirms customer adoption momentum but does not provide financial impact or timelines; monitor future releases for contract size, deployment details, or revenue recognition that would affect results.